Introduction: Glycogen synthase kinase-3 (GSK-3) is recognized as a crucial player in many
cellular functions and its activity is tightly controlled by complex mechanisms that are each …

Glycogen synthase kinase-3β (GSK3β) is a fascinating enzyme with an astoundingly diverse
number of actions in intracellular signaling systems. GSK3β activity is regulated by serine …

Glycogen synthase kinase-3 (GSK3), which is inhibited by serine-phosphorylation, is
involved in the neuropathology of Alzheimer's disease (AD). We tested if the two therapeutic …

Activity of glycogen synthase kinase-3β (GSK-3β) is required for long-term depression (LTD)
via molecular mechanisms that are incompletely understood. Here, we report that PSD-95, a …

J. Neurochem.(2008) 104, 1433–1439. Abstract Glycogen synthase kinase 3 (GSK3) is a
constitutively active, proline‐directed serine/threonine kinase that plays a part in a number of …

Understanding the molecular signaling pathways that go awry in Alzheimer's disease (AD)
would provide insights into developing novel therapies for this devastating …

There is an increasing awareness that diabetes has an impact on the central nervous
system, with reports of impaired learning, memory, and mental flexibility being more …

Emerging evidence has suggested that glycogen synthase kinase 3 (GSK-3) is a key
regulatory kinase involved in a plethora of processes in the nervous system, including …

Although glycogen synthase kinase 3β (GSK3β) is emerging as a prominent drug target in
the treatment of neurodegenerative diseases such as Alzheimer's disease (AD) and stroke …

Abstract Glycogen synthase kinase‐3 (GSK3) is a crucial enzyme contributing to the
regulation of neuronal structure, plasticity and survival, is implicated as a contributory factor …